The administration of raclopride, a dopamine D2 antagonist, significantly improved sensorimotor gating in both Sp4 heterozygous and homozygous mice but not in wildtype mice, suggesting that dopamine neurotransmission may be altered in Sp4 mutant mice as it is in human psychiatric disorders. This evidence concerns the gene SP4 and psychiatric disorder.